N. Kathuria-Prakash

Multicenter Safety and Practice for Off-Label Diagnostic Use of Ferumoxytol in MRI.

J. Finn, M. Fogel, A. Radjenovic, 2019, Radiology.

Immunotherapy and Metastatic Renal Cell Carcinoma: A Review of New Treatment Approaches

A. Drakaki, N. Kathuria-Prakash, C. Drolen, 2021, Life.

Young African American women’s participation in an m-Health study in cardiovascular risk reduction: Feasibility, benefits, and barriers

N. Alshurafa, K. Watson, N. Kathuria-Prakash, 2019, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.

Optimal Thyroid Hormone Replacement Dose in Immune Checkpoint Inhibitor-Associated Hypothyroidism is Distinct from Hashimoto's Thyroiditis.

A. Drakaki, T. Angell, N. Kathuria-Prakash, 2022, Thyroid : official journal of the American Thyroid Association.

Factors Associated With Hospitalization Among Breast Cancer Patients With COVID-19: A Diverse Multi-Center Los Angeles Cohort Study

Nicholas Hornstein, Alexander W. Sun, N. Kathuria-Prakash, 2021, Clinical Breast Cancer.

COVID-19 Outcomes of Patients With Differentiated Thyroid Cancer: A Multicenter Los Angeles Cohort Study

N. Kathuria-Prakash, M. Lechner, M. Su, 2021, Endocrine Practice.

The Potential Revolution of Cancer Treatment with CRISPR Technology

A. Pantuck, Melissa L. Abel, Alexander W. Sun, 2023, Cancers.

Generalizability of PRS313 for breast cancer risk amongst non-Europeans in a Los Angeles biobank

Jacob M. Luber, Parisa Boodaghi Malidarreh, B. Pasaniuc, 2023, 2305.03893.